Steven Daviss is the chair of the department of psychiatry at Baltimore Washington Medical Center. He also holds several other roles related to behavioral health, electronic health records, and health information exchange. He presented on strategic planning and innovation in healthcare organizations. He discussed a study validating the M3 screening tool, which can reliably screen for several mental health conditions in 3 minutes. The tool provides automated scoring and clinical decision support to help providers.

1. Steven
R
Daviss
MD,
CMIO
Chair,
Dept
of
Psychiatry
Baltimore
Washington
Medical
Center
steve.daviss@m-­‐3information.com
OPEN
MINDS
Planning
&
Innovation
Institute
|
June
6,
2012
|
New
Orleans
1

2. Other
Hats
I
Wear
 Department
chair,
Baltimore
Washington
Medical
Center
 Chair,
APA
Committee
on
EHRs
 URAC
Health
Standards
Committee
 HIE
Policy
Board,
Md
Health
Care
Commission
 Co-­‐chair,
CCHIT
Behavioral
Health
Work
Group
 Shrink
Rap/My
Three
Shrinks
2

3. Strategic
Planning
+
Innova1ve
Thinking
 How
you
strategically
position
your
organization
for
success
 How
you
market
you
organization
to
both
consumers
and
payers
 How
you
harness
new
industry
innovations
within
your
organization
3

4. M3
Team
 Michael
Byer
 Larry
Culpepper
MD
 Steven
Daviss
MD
 Gerald
Hurowitz
MD
 Robert
Post
MD
 Herbert
C
Schulberg
MD
4

5. Annals
of
Family
Medicine,
2010
5

6. Study
 647
consecutive
adults
seeking
care
in
an
academic
family
medicine
clinic,
2007-­‐2008
 Participants
completed
M3
in
the
waiting
room
 Within
30
days
of
visit,
the
Mini
International
Neuropsychiatric
Interview
(MINI)
was
administered
by
phone
(reference
standard)
by
blinded
Master’s
level
clinicians
 Psychometric
properties
determined
6

7. Demographics
 Age:
45
(18-­‐92)
 Gender:
71%
female
 Race:
67%
white,
28%
black,
5%
other
 Marital:
48%
married,
28%
single,
12%
divorced
 Education:
4%
-­‐HS,
36%
HS,
27%
college,
19%
grad
 Employment:
21%
unemployed,
64%
employed
7

8. M3:
In
past
2
weeks…
 Major
Depression:
7
questions
 GAD:
2
questions
 Social
anxiety:
1
question
 OCD:
3
questions
 PTSD:
4
questions
 Bipolar
disorder:
4
questions
(lifetime
hx)
 Functional
impairment:
4
questions
8

9. 2-­‐Stage
Scoring
1. Functional
impairment
gateway
(suicide
&
functional
impairment
questions)
2. Symptom
scores
(0,0,1,2,2)
3. Optimal
cutpoints
determined
based
on
sensitivity
and
specificity,
and
using
two
different
methods
9

10. Screening
Metrics
Negative
Score
Sensitivity
Specificity
Predictive
Value
TOTAL
0.83
0.76
89%
Major
Depression
0.84
0.80
95%
Bipolar
Disorder
0.88
0.70
98%
PTSD
0.88
0.76
99%
Anxiety
Disorder
0.82
0.78
92%
10

11. Bipolar
Depression
Anxiety
11

12. 12

13. WhatsMyM3 Features
 Multidimensional
 Evidence-­‐based
 One
number
 Quick
 Functional
impairment
 Probes
D&A
misuse
 Consumer
engagement
 Multiplatform:
web,
iPhone,
iPad,
Android
 Clinical
decision
support
13

14. 14

15. DEMO
A
live
demonstration
of
M3
Clinician
was
performed
at
the
meeting.
I
am
including
some
screenshots
to
illustrate
how
the
M3
Clinician
tool
is
used
in
a
clinical
practice
to
screen
patients
and
track
their
symptoms.
Most
providers
are
having
patients
complete
the
3-­‐minute
M3
screen
in
the
waiting
room
on
an
iPad.
The
M3
Clinician
app
is
a
free
download
(http://
bit.ly/m3clinicianapp)
and
the
service
is
$0.49-­‐$1.22
per
screen
depending
on
volume.
More
information
at
http://m3clinician.com.
steve.daviss@m-­‐3clinician.com
15

16. M3 Clinician™
M3 PATIENT ASSESSMENT
Progress Current
Quarter MICHAEL CORLEONE
Email: wuchoolookinat@nostra. MPI:
com
Gender: M DOB: 07/04/1951
Last Screen Score: 30 Date of Last Screen: 06/05/2012
FUNCTIONAL IMPAIRMENT
M3Clinician
Suicidality: Not at all
Report:
Family:
Work/School:
Not at all
Not at all
Substance Use: Rarely
Alcohol: Most of the time
Note
how
symptom
DIMENSION
tracking
picked
up
Clinical Syndrome Result Reference Out of range
on
Mr.
Corleone’s
Depression
Anxiety
2
2
0-4
0-2
No
No
development
of
PTSD
Bipolar
0
8
0-1
0-1
No
Yes
manic
symptoms
RECENT SCREENS
after
being
started
DATE TAKEN SCORE
on
an
antidepressant.
06/05/2012
05/29/2012
30
30
05/22/2012 38
MEDICATIONS PRESCRIBED
Name Dosage Freq Start D/C'd
Depakote 500mg BID 06/06/2012
Effexor 100mg qAM 05/30/2012 06/06/2012
Effexor 50mg qAM 05/23/2012 05/29/2012
THERAPY
Type Freq Start D/C'd
Dialectical qweek 05/29/2012
Behavioral
Therapy
Alcoholics 3x/wk 05/25/2012
SIDE EFFECTS Anonymous 16
ADHERENCE PROBLEMS
Gastrointestinal
Sexual Dysfunction Date Medication Reason
Weight/Appetite Change No adherence problems for medication has been added yet.

17. Multiple
users
can
be
added
to
the
account
at
no
extra
cost,
and
different
roles
can
be
assigned.
17

18. This
is
the
Role
Management
screen
where
roles
can
be
defined
as
to
what
features
and
clinical
information
is
available
to
each
role.
18

19. These
are
the
features
and
details
that
can
be
enabled
for
different
roles.
19

20. View
of
sortable
patient
list.
20

21. This
is
the
Report
page
that
comes
with
M3
Clinician.
Unlimited
reports
can
be
designed
based
on
all
available
data.
21

22. Results
of
one
report,
showing
patients
with
high
depression
scores
over
the
past
3
months.
Each
column
can
be
sorted
by
clicking
on
the
header.
22

23. This
is
the
report
creation
tool,
which
is
highly
customizable.
23

24. Thank
you.
24

25. 25